Skip to content
★ Sign in to follow
CM

C-MER Medical Holdings Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$1.1BHealth Care

No insider purchase over the last 90 days. The latest, by LEE Yau Wing Vincent, was filed 12 Dec 2025.

C-MER Medical Holdings Ltd.: what insiders have been doing

C-MER Medical Holdings Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. In the past year (8 November 2025 to 8 November 2026), 3 filings came from 3 insiders.

On the market, 2 insiders bought (2 purchases) while 1 insider sold (1 sale). The totals exclude 3 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 2 senior executives.

With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 1,323 companies we follow on the same exchange. The full history, which starts in 2018, counts 65 purchases against 9 sales.

The last insider purchase was made public on 12 December 2025, 332 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
158
Thresholds
n/a
Buy Volume
€57M
65 ops. · all time
Sell Volume
€184M
9 ops. · all time

Who traded when

BuySale
AUYEUNG Rex Pak-kuen1 sale
LEE Yau Wing Vincent1 buy
LI Xiaoting1 buy

Since the insiders bought

  • Filed 17 Sept 2024 · 783 days ago · €41k
    -8.5%
    Entry HK$2.11 · Close at T+365 HK$1.93
  • Filed 17 Jul 2024 · 845 days ago · €47k
    -33.5%
    Entry HK$2.69 · Close at T+365 HK$1.79
  • Filed 08 Jun 2021 · 1980 days ago · €172k
    -33.0%
    Entry HK$6.70 · Close at T+365 HK$4.49

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 3,762 of 26,911 companies
71.0
score / 100
Value
89
Quality
53
FCF yld19%
Earn yld9.4%
EV/EBITDA4.0x
ROE5.7%
Gross mgn31%
Net mgn5.2%
Debt/EBITDA1.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.91
Analyst consensus
·
Income statement
RevenueHK$1.9B
Gross profitHK$603.7M31% margin
EBITDAHK$378.6M19% margin
Net incomeHK$100.4M5.0% margin
Valuation
PER (trailing)11.3x
P/Book0.6x
Beta0.52
Balance sheet & cash
Market capHK$1.1B
Total debtHK$426.8M
Free Cash FlowHK$202.3M
Debt / Equity22%
Profitability & ownership
ROE5.7%
ROA3.7%
% insiders58.5%
% institutions1.8%
Last declaration on 4 September 2026
Declarations158 total
  • ▼
    DirectorExecutives
    0HKEX
    66,666 sharesShareXHKGHKEX:DA20260903E00375
  • ▲
    DirectorExecutives
    0HKEX
    13,203,000 sharesShareXHKGHKEX:DA20251212E00332
    Canonical exit: 11 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    691,786,553 sharesShareXHKGHKEX:DA20251212E00317
    Canonical exit: 11 Mar 2026 (T+90)
  • ●
    DirectorExecutives
    683,100 HKD19HKEX
    300,000 shares@ HK$2.277100.0% of flowShareXHKGHKEX:DA20250602E00328
  • ▲
    DirectorExecutives
    353,005 HKD23HKEX
    170,000 shares@ HK$2.07650.0% of flowShareXHKGHKEX:DA20240917E00301
    Canonical exit: 16 Dec 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    353,005 HKD23HKEX
    170,000 shares@ HK$2.07650.0% of flowShareXHKGHKEX:DA20240917E00302
    Canonical exit: 16 Dec 2024 (T+90)
  • ▲
    DirectorExecutives
    776,074 HKD23HKEX
    380,000 shares@ HK$2.04230.0% of flowShareXHKGHKEX:DA20240916E00194
    Canonical exit: 15 Dec 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    776,074 HKD23HKEX
    380,000 shares@ HK$2.04230.0% of flowShareXHKGHKEX:DA20240916E00197
    Canonical exit: 15 Dec 2024 (T+90)
  • ▲
    DirectorExecutives
    759,519 HKD23HKEX
    374,000 shares@ HK$2.03080.0% of flowShareXHKGHKEX:DA20240913E00365
    Canonical exit: 12 Dec 2024 (T+90)
  • ▲
    DirectorExecutives
    514,275 HKD23HKEX
    250,000 shares@ HK$2.05710.0% of flowShareXHKGHKEX:DA20240913E00364
    Canonical exit: 11 Dec 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    514,275 HKD23HKEX
    250,000 shares@ HK$2.05710.0% of flowShareXHKGHKEX:DA20240913E00369
    Canonical exit: 11 Dec 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    759,519 HKD23HKEX
    374,000 shares@ HK$2.03080.0% of flowShareXHKGHKEX:DA20240913E00370
    Canonical exit: 12 Dec 2024 (T+90)
  • ▲
    DirectorExecutives
    920,251 HKD23HKEX
    348,000 shares@ HK$2.64440.0% of flowShareXHKGHKEX:DA20240722E00440
    Canonical exit: 20 Oct 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    920,251 HKD23HKEX
    348,000 shares@ HK$2.64440.0% of flowShareXHKGHKEX:DA20240722E00442
    Canonical exit: 20 Oct 2024 (T+90)
  • ▲
    DirectorExecutives
    494,948 HKD23HKEX
    188,000 shares@ HK$2.63270.0% of flowShareXHKGHKEX:DA20240719E00343
    Canonical exit: 17 Oct 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    494,948 HKD23HKEX
    188,000 shares@ HK$2.63270.0% of flowShareXHKGHKEX:DA20240719E00345
    Canonical exit: 17 Oct 2024 (T+90)
  • ▲
    DirectorExecutives
    455,005 HKD23HKEX
    170,000 shares@ HK$2.67650.0% of flowShareXHKGHKEX:DA20240718E00404
    Canonical exit: 16 Oct 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    455,005 HKD23HKEX
    170,000 shares@ HK$2.67650.0% of flowShareXHKGHKEX:DA20240718E00408
    Canonical exit: 16 Oct 2024 (T+90)
  • ▲
    DirectorExecutives
    840,864 HKD23HKEX
    320,000 shares@ HK$2.62770.0% of flowShareXHKGHKEX:DA20240717E00665
    Canonical exit: 15 Oct 2024 (T+90)
  • ▲
    DirectorExecutives
    402,038 HKD23HKEX
    153,000 shares@ HK$2.62770.0% of flowShareXHKGHKEX:DA20240717E00669
    Canonical exit: 15 Oct 2024 (T+90)
  • ▲
    DirectorExecutives
    837,856 HKD23HKEX
    320,000 shares@ HK$2.61830.0% of flowShareXHKGHKEX:DA20240717E00664
    Canonical exit: 14 Oct 2024 (T+90)
  • ▲
    DirectorExecutives
    398,255 HKD23HKEX
    152,000 shares@ HK$2.62010.0% of flowShareXHKGHKEX:DA20240717E00663
    Canonical exit: 13 Oct 2024 (T+90)
  • ▲
    DirectorExecutives
    400,875 HKD23HKEX
    153,000 shares@ HK$2.62010.0% of flowShareXHKGHKEX:DA20240717E00667
    Canonical exit: 13 Oct 2024 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Lam Shun Chiu Dennis, counted once

    837,856 HKD23HKEX
    320,000 shares@ HK$2.61830.0% of flowShareXHKGHKEX:DA20240717E00668
    Canonical exit: 14 Oct 2024 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    250,000 sharesShareXHKGHKEX:DA20240322E00292

25 of 158 declarations

About C-MER Medical Holdings Ltd.

C-MER Medical Holdings Ltd. is a healthcare company specializing in ophthalmology services. It focuses on providing high-quality medical care and innovation in eye treatments.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations